News articles about Cardiovascular Systems (NASDAQ:CSII) have trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cardiovascular Systems earned a daily sentiment score of 0.17 on Accern’s scale. Accern also gave press coverage about the medical device company an impact score of 45.6750650797132 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Several research firms recently weighed in on CSII. William Blair reiterated a “market perform” rating on shares of Cardiovascular Systems in a report on Thursday, December 21st. BidaskClub downgraded shares of Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a report on Wednesday, January 10th. Needham & Company LLC reiterated a “buy” rating and issued a $36.00 target price (down previously from $37.00) on shares of Cardiovascular Systems in a report on Thursday, October 26th. Zacks Investment Research downgraded shares of Cardiovascular Systems from a “hold” rating to a “sell” rating in a report on Tuesday, October 10th. Finally, Raymond James Financial reiterated a “hold” rating on shares of Cardiovascular Systems in a report on Monday, December 4th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $31.50.
Shares of Cardiovascular Systems (CSII) opened at $25.33 on Wednesday. Cardiovascular Systems has a 1-year low of $23.00 and a 1-year high of $33.11. The company has a debt-to-equity ratio of 0.18, a current ratio of 4.30 and a quick ratio of 3.83. The firm has a market cap of $838.05, a P/E ratio of -422.17 and a beta of 2.52.
Cardiovascular Systems (NASDAQ:CSII) last posted its earnings results on Wednesday, October 25th. The medical device company reported ($0.06) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.08) by $0.02. Cardiovascular Systems had a negative net margin of 0.93% and a positive return on equity of 0.74%. The firm had revenue of $49.70 million during the quarter, compared to the consensus estimate of $51.00 million. During the same quarter last year, the firm earned ($0.06) EPS. The firm’s revenue for the quarter was down .2% on a year-over-year basis. equities analysts expect that Cardiovascular Systems will post -0.03 earnings per share for the current fiscal year.
WARNING: This article was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/17/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-cardiovascular-systems-csii-stock-price.html.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.